Agreed. No much volatility on the market to acquire a large position. Who knows, may even be a large placement and they pay overs. SP has certainly been pushed down constantly lately and I doubt it is retail capitulating due to the general consensus of Medlabs potential. This placement should see us through to a net positive income stream and the last of the dilution. IMO of course.
Add to My Watchlist
What is My Watchlist?